ELISPOT detection kit for detecting bovine brucellosis

A detection kit, the technology of Brucella bovis, applied in the field of diagnosis of bovine brucellosis, the field of ELISPOT detection kits for detecting bovine brucellosis, can solve the problem of unsatisfactory specificity and the inability to meet the requirements of bovine Brucella Specific detection of bacterial infection, can not meet the early detection of Brucella bovine infection and other problems, to eliminate the interference of false positives, good specificity, strong affinity

Active Publication Date: 2016-07-13
YANGZHOU UNIV
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] But above-mentioned detection method still can not satisfy the real needs of the specific detection of this area to the bovine Brucella infection;
[0006] Although ELISA is

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • ELISPOT detection kit for detecting bovine brucellosis
  • ELISPOT detection kit for detecting bovine brucellosis
  • ELISPOT detection kit for detecting bovine brucellosis

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0019] As an embodiment of the present invention, the first bovine interferon gamma monoclonal antibody is bovine interferon gamma monoclonal antibody 2G5, and the bovine interferon gamma monoclonal antibody 2G5 is obtained from the hybridoma with the deposit number of CCTCCNO: C2012107 It is secreted and produced by cell line 2G5 or its passage cell line; and the second bovine interferon gamma monoclonal antibody is bovine interferon gamma monoclonal antibody 5E11, and the bovine interferon gamma monoclonal antibody 5E11 has an accession number of CCTCCNO: C2012108 Secreted by the hybridoma cell line 5E11 or its passage cell lines.

[0020] Hybridoma cell line 2G5 and hybridoma cell line 5E11 are disclosed in patent CN102965343B.

[0021] As an embodiment of the present invention, the supporting medium is a microporous filter membrane plate. More preferably, the supporting medium is a microporous culture plate coated with PVDF film. Wherein, preferably, there is a PVDF membrane ...

Example Embodiment

[0047] Example 1 Preparation of the Br-PPD-based ELISPOT detection kit for bovine brucellosis of the present invention

[0048] The assembly steps of ELISPOT kit are as follows:

[0049] 1) Purification of bovine interferon gamma monoclonal antibody 2G5

[0050] The hybridoma cell line secreting the bovine interferon-gamma monoclonal antibody 2G5 was injected into the abdominal cavity of mice. After ascites was produced, the ascites was collected, and the collected 2G5 ascites was purified by the ProteinG affinity chromatography method.

[0051] 2) Preparation of biotin-labeled bovine interferon gamma monoclonal antibody (denoted as Bio-5E11)

[0052] The hybridoma cell line secreting the bovine interferon-gamma monoclonal antibody 5E11 was injected into the abdominal cavity of mice. After ascites was produced, the ascites were collected, and the collected 5E11 ascites was purified by the ProteinG affinity chromatography method.

[0053] The purified 5E11 monoclonal antibody is labeled w...

Example Embodiment

[0064] Example 2 Detection of bovine peripheral blood samples by ELISPOT detection kit based on non-specific stimulant PWM

[0065] 1. Experimental materials

[0066] The ELISPOT detection kit for bovine brucellosis prepared in Example 1 was used.

[0067] 2. Anticoagulant blood incubation and detection

[0068] ① Take 1 mL of bovine blood aseptically and add it to a blood collection tube containing heparin sodium, and then mix it upside down after blood collection to obtain anticoagulant blood;

[0069] ②Add the following reagents to the above-mentioned coated 96-well filter plate: each anticoagulant sample includes 2 test wells, 50μL cell culture fluid to the negative control well, 50μL cell culture fluid diluted PWM to the positive control well (final The concentration is 5μg / mL), add 50μL of bovine anticoagulant blood to each well, and place the 96-well filter plate at 37℃, 5% CO 2 Incubate for 24-48 hours;

[0070] ③Remove the 96-well filter membrane plate, discard the culture supe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an ELISPOT detection kit for detecting bovine brucellosis.The ELISPOT detection kit comprises a supporting medium, a capture antibody, a detection antibody, a negative control, a positive control and a specificity irritant, wherein the capture antibody is the first bovine gamma interferon monoclonal antibody, the detection antibody is the second marked bovine gamma interferon monoclonal antibody, and the specificity irritant is brucellin Br-PPD.A micropore filter membrane is arranged on a contact face of the supporting medium and the reagent.The capture antibody coats the supporting medium or the capture antibody and the supporting medium are placed respectively.The capture antibody and the detection antibody can be subjected to the antigen antibody combination effect together with bovine gamma interferon.According to the detection kit, the adopted monoclonal antibody excreted by hybrid tumor cell strains has the advantages of being high in active valence, good in specificity and strong in natural antigen affinity.Compared with a brucellosis antibody ELISA detection kit, the ELISPOT can achieve early detection of bovine brucellosis infection, false positive interference brought by a cross reaction is eliminated, and the good specificity is shown.

Description

technical field [0001] The invention relates to a detection kit, in particular to an ELISPOT detection kit for detecting bovine brucellosis and its application in the field of bovine brucellosis diagnosis. Background technique [0002] Bovine brucellosis (hereinafter referred to as "bull brucellosis") is a zoonotic chronic infectious disease caused by Brucella. After infection, livestock will have symptoms such as infertility and abortion, and bulls will have arthritis and orchitis. The ability to breed has declined significantly, seriously threatening the health of the herd, and causing great harm to animal husbandry production and human health. [0003] Brucella is a facultative intracellular parasite that induces a cellular immune response after infection. The cellular immune response can produce a series of cytokines, which play an important role in the body's defense against infection. When the body is infected with Brucella, specific immunogenic proteins can activate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N33/577G01N33/569
CPCG01N33/56911G01N33/577G01N33/6866G01N2333/57
Inventor 焦新安陈祥徐正中孟闯刘佳莹潘志明孙林
Owner YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap